Stock Newsletters and Investment Newsletters from QualityStocks for 8/2/07

BioSante Pharmaceuticals, Inc. (BPA) previously at $5.49 up 3% at $5.68 with 67,500 (BPA) was highlighted by Knobias Clip Report (BPA) has a 52 week range of 1.48 - 8.00

BioSante Pharmaceuticals, Inc. announced this month that they recieved positive results from Medical Aesthetics Technology Corporation ("MATC") associated with the use of its calcium phosphate nanotechnology (CaP) as a potential wrinkle filler in cosmetic medicine. Preliminary results indicate long lasting effects and no adverse events.Human clinical testing of CaP for this use is being planned. The company also announced this month that its vaccine adjuvant, BioVant(TM), may serve as an effective vaccine adjuvant for the development of a dose sparing vaccine against H5N1 avian flu.

BioSante Pharmaceuticals, Inc. engages in the licensing and development of hormone therapy products to treat men and women.

IA Global, Inc. (IAO) closed today $0.49 with 68,400 shares traded (IAO) has a 52 week trading range of $0.08 to $0.65

IA Global, Inc. announced this week that it will change its year-end from December 31 to March 31 effective for the fiscal year ended March 31, 2008. IA Global, Inc.CEO, Derek Schneideman, said, "We are pursuing a large pipeline of potential acquisition targets and to facilitate consistent year-end reporting, we are changing our year-end to match the March 31 year-end typically used by Asian firms, including Global Hotline, Inc. The company anticipates revenues for the twelve months ending March 31, 2008 at approximately $47-$55 million, or a 114%-150% increase over the prior year period."

IA Global, Inc. ("IA Global") is a strategic holding Company with a dedicated focus on growth through mergers and acquisitions in the Pacific Rim region.

Ener1, Inc. (ENEI) closed today at $0.28 with 9,599 shares traded (ENEI) has a 52 week trading range of $0.18 to $0.44

Ener1, Inc. announced in late June that its controlling shareholder, Ener1 Group would invest up to $15 million in Ener1 through the purchase of newly issued shares of common stock. The funds will help the company continue its commercial development of lithium ion batteries for hybrid electric vehicles, as well as the product launch of its fuel-cell-powered surveillance camera. The funding is conditioned upon the completion of a minimum number of lithium ion HEV battery packs, as well as achievement of a minimum level of sales of the portable fuel-cell powered surveillance camera product currently in development.

Ener1, Inc., through its subsidiaries, engages in the development and marketing of Lithium-ion batteries, fuel cells, and nanotechnology-related manufacturing processes and materials.

ZAGG Inc. (ZAGG) previously at $1.86 up 1.61% at $1.89 with 31,142 shares traded

ZAGG Inc. that its common shares have been approved for trading in the Over-The-Counter Bulletin Board Market, and will trade under the new company symbol ZAGG The company markets and sells its patent-pending invisibleSHIELD(TM) a protective, high-tech film covering, foruse with iPods, laptops, cell phones, PDAs, watch faces, gaming devices, digital camera,offering over 1,000 designs with a lifetime replacement warranty

ZAGG Inc. designs, markets, and sells protective coverings called the invisibleSHIELD(TM) for consumer electronic and hand-held devices primarily in the United States and Europe.

QPC Lasers, Inc. (QPCI) previously at $1.24 up 8% at $1.35 with 145,778 shares traded. (QPCI) was highlighted recently by Taglich, OTC Picks, TradersWorks and OTC Stock Exchange

QPC Lasers, Inc. announced today that it expects total revenue to be $1.8 Million for the quarter, representing more than 300% growth compared to the second quarter of 2006. QPC Lasers, Inc. shares surged 119% on 6/27/07, after the company unveiled its new BrightLase® Seed Laser at the Solid State and Diode Laser Technology Review in Los Angeles, California, in late June. The BrightLase® Seed Laser can be used in a wide variety of applications including defense (long range atmospheric sensing, missile defense and range finding), industrial drilling and marking. The laser provides up to ten times more power than other available diode based seed lasers in a package up to ten times more compact and lightweight than traditional solid state or fiber based seed lasers. The company announced today that it has shipped the initial shipments of its BrightLase(TM) high power seed lasers to a US-based customer developing high-energy fiber lasers for directed energy weapons applications.

QPC Lasers, Inc. engages in the design and manufacture of semiconductor lasers for various industrial, medical, and defense markets in the United States.

And now for a look at todays big movers....

Material Technologies, Inc. (MTTG) previously at $1.02 up 36% at $1.39 with 686,377 shares traded. (MTTG) was highlighted today in The Bull Report, StockEgg.com, Shazam Stocks, OTC Picks, and Hot Stock Chat

Material Technologies, Inc. Brent Phares, Ph.D., Chief Engineer of Material Technologies Inc., was featured on Fox News yesterday, where he commented on the highway bridge collapse in Minneapolis calling the disaster a sign of America's widespread problem with its aging infrastructure. Material Technologies, Inc. Material Technologies, Inc. has the only nondestructive field testing device able to find growing cracks inbridge structural members as small as 0.01 inches in length and some non-surface breaking cracks. The companies Electrochemical Fatigue Sensor (EFS) technology can find growing cracks in the bridges allowing the State's bridge engineers to fix the specific bridges in the priority of bridges in the most need of repair, and its Fatigue Fuse Can Determine Actively Growing Cracks in Bridges and Continuously Monitor Accumulated Fatigue in Real-Time.

Material Technologies, Inc. is an engineering, research and development company specializing in technologies to measure microscopic fractures and flaws in metal structures and monitor metal fatigue in real time. They utilize leading edge metal fatigue detection, measurement and monitoring solutions metal structures and equipment including bridges, railroads, airplanes, ships, cranes, power plants, mining equipment, piping systems and heavy iron.

Clinicares Co. Ltd. (CCRC) previously at $0.20 up 50% at $0.30 with 57,500 shares traded. (CCRC) was highlighted today by OTC Reporter and this month by Wise Alerts, GMCR, OTC Reporter, OTC Picks and Stock Egg.com

Clinicares Co. Ltd. FKA Vision Digital Multimedia Corporation announced in April that it has completed the acquisition of Clinicares Co. Ltd. and has changed its name to Clinicares, Inc. The company's primary focus and product line is Clinicares Treatment Solutions (CTS) The companies product lines are aimed at replacing dermabrasion, chemical and laser resurfacing as a new drug delivery system with the microneedle-roller for clinical and consumer use. The company announced in May that it had signed of a contract with the People's Liberation Army Hospital in Beijing, China to provide their functional beauty products, customized beauty products and their DNA Gene testing/diagnosis services. The company anticipates high demand for their products and services, Clinicares forecasts a significant increase in sales, Due to the size of the Chinese market. GMCR stated today " After an extended quiet period, this one is coming back strong. Watch for continuation of the uptrend and greater volume on uptrending price."

Through the acquisition of Clinicares Co. Ltd., VDGM opertates as a Biotech development stage company involved in R&D, Manufacturing, Distribution and Marketing of its proprietary products in the anti-aging, cosmeceutical, and beauty aid fields with both branded and private label activities.

Octillion Corp. (OCTL) previously at $2.97 up 14% at $3.40 with 1,571,568 shares traded. (OCTL) was highlighted today by GMCR, and recently by Investment House, StockEgg.com, HotOTC.com, Vital Stocks and The Online Investor

Octillion Corp. shares have continued to gain momentum after the company announced that it has doubled its research funding in order to accelerate development of the first-of-its-kind transparent glass window capable of generating electricity. The breakthrough was made possible through the use of Octillion's transparent NanoPower Windows is a proprietary spray coating of a silicon nanoparticle film, which is fluorescent and able to convert the sun's energy into electricity. The film was able to successfully convert high energy photons into lower energy photons, thus optimizing electrical conversion by preventing high energy photons from being unnecessarily wasted through conversion into heat.

Octillion Corp., together with its wholly owned subsidiaries, is a technology incubator focused on the identification, acquisition, development and eventual commercialization of emerging technologies.

Inova (IVTH) previously at $0.017 up 23% at $0.021 with 6,649,528 shares traded

Inova announced an agreement yesterday to aquire Texas-based Desert Communications for $5.5 million. Inova will pay $3 million cash on closing and a $2.5 million note payable over three years. The transaction is expected to close during the month of August 2007. Both companies had been developing three RFID pilots together for schools, libraries and prisons. Desert provides IT services to a customer base that primarily consists of Texas-based school districts, local government entities and corporations. The company also announced that Right Tag, an Inova Technology company, has received an order for RFID scanners from British Telecom.

Inova Technology operates in two business units: one develops RFID products and the other provides IT services and data storage solutions. RightTag is the RFID subsidiary of Inova. RightTag's current RFID product line includes handheld scanners, desktop scanners, PC boards, printers, and tags.

CryoCor Inc. (CRYO) previously at $4.20 up 10% at $4.63 withy 1,268,710 shares traded. (CRYO) was highlighted today by OTC Picks

CryoCor Inc. shares were boosted today on the announcement that the Food and Drug Administration granted pre-market approval for its heart device. Today's announcement from the FDA gives CryoCor's product approval for treatment of right atrial flutter, an abnormality of the heart rhythm. CryoCor stated that it plans to begin selling its cryoablation system in the United States over the next several months. CryoCor Inc. shares jumped in June on the announcement that CryoCor Inc. will collaborate with medical device maker Boston Scientific Corp. to develop products that treat irregular heartbeat, the companies will collaborate on the development of cryoablation, or extreme cold, to treat irregular heartbeat, or, cardiac arrhythmias. Boston Scientific agreed to buy $2.5 million in CryoCor stock in the deal, and could buy another $2.5 million based on development milestones. CryoCor will receive payments based on those milestones and future royalties.

CryoCor, Inc., a medical technology company, engages in the development and manufacture of minimally invasive and disposable catheter systems for the treatment of cardiac arrhythmias in the United States.